Anixa Biosciences is trading 6.1% up in pre-market at $2.95 on October 23, 2026; CEO Amit Kumar’s reported purchase may be drawing attention, but its connection to the move is unconfirmed. - Kumar bought 8,000 shares at $2.72 apiece on October 22. - No separate company announcement explaining the pre-market rise was found. - Available information does not establish pre-market volume or activity levels.